Surgalign Holdings Inc. [SRGA] Revenue clocked in at $94.90 million, down -67.59% YTD: What’s Next?

Related

Surgalign Holdings Inc. [NASDAQ: SRGA] stock went on a downward path that fall over -2.38% on Wednesday, amounting to a one-week price decrease of less than -9.64%. The company report on December 20, 2021 that Surgalign Holdings, Inc. to Present at the 2022 H.C. Wainwright Virtual BioConnect Conference.

Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced that the management team will participate in the 2022 H.C. Wainwright Virtual BioConnect Conference taking place January 10-13, 2022.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


A recording of the Company’s presentation will be available Monday, January 10, 2022 at 7am ET. To access please visit the investor relations page of the Company’s website at surgalign.com/investors/. Replays of the webcasts will be archived on the website for approximately 90 days.

Over the last 12 months, SRGA stock dropped by -70.18%. The one-year Surgalign Holdings Inc. stock forecast points to a potential upside of 75.09. The average equity rating for SRGA stock is currently 1.70, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $95.04 million, with 138.32 million shares outstanding and 122.75 million shares in the current float. Compared to the average trading volume of 2.09M shares, SRGA stock reached a trading volume of 4195588 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Surgalign Holdings Inc. [SRGA]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SRGA shares is $2.85 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SRGA stock is a recommendation set at 1.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Craig Hallum have made an estimate for Surgalign Holdings Inc. shares, keeping their opinion on the stock as Hold, with their previous recommendation back on September 28, 2021. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on February 03, 2021, representing the official price target for Surgalign Holdings Inc. stock. Previously, the target price had yet another raise to $4, while Piper Sandler analysts kept a Overweight rating on SRGA stock.

The Average True Range (ATR) for Surgalign Holdings Inc. is set at 0.06, with the Price to Sales ratio for SRGA stock in the period of the last 12 months amounting to 1.00. The Price to Book ratio for the last quarter was 2.09, with the Price to Cash per share for the same quarter was set at 0.51.

SRGA Stock Performance Analysis:

Surgalign Holdings Inc. [SRGA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.64. With this latest performance, SRGA shares dropped by -5.36% in over the last four-week period, additionally sinking by -48.94% over the last 6 months – not to mention a drop of -70.18% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SRGA stock in for the last two-week period is set at 39.39, with the RSI for the last a single of trading hit 37.54, and the three-weeks RSI is set at 39.94 for Surgalign Holdings Inc. [SRGA]. The present Moving Average for the last 50 days of trading for this stock 0.8644, while it was recorded at 0.7732 for the last single week of trading, and 1.3333 for the last 200 days.

Insight into Surgalign Holdings Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Surgalign Holdings Inc. [SRGA] shares currently have an operating margin of -77.24 and a Gross Margin at +56.75. Surgalign Holdings Inc.’s Net Margin is presently recorded at -190.86.

Return on Total Capital for SRGA is now -51.72, given the latest momentum, and Return on Invested Capital for the company is -303.69. Return on Equity for this stock declined to -310.35, with Return on Assets sitting at -83.13. When it comes to the capital structure of this company, Surgalign Holdings Inc. [SRGA] has a Total Debt to Total Equity ratio set at 7.65. Additionally, SRGA Total Debt to Total Capital is recorded at 7.11, with Total Debt to Total Assets ending up at 1.51. Long-Term Debt to Equity for the company is recorded at 4.96, with the Long-Term Debt to Total Capital now at 4.61.

Reflecting on the efficiency of the workforce at the company, Surgalign Holdings Inc. [SRGA] managed to generate an average of -$985,761 per employee. Receivables Turnover for the company is 2.08 with a Total Asset Turnover recorded at a value of 0.44.Surgalign Holdings Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.00 and a Current Ratio set at 2.50.

SRGA Stock EPS

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SRGA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Surgalign Holdings Inc. go to 15.00%.

>> 7 Top Picks for the Post-Pandemic Economy <<

Surgalign Holdings Inc. [SRGA] Insider Position Details

There are presently around $33 million, or 40.00% of SRGA stock, in the hands of institutional investors. The top three institutional holders of SRGA stocks are: KRENSAVAGE ASSET MANAGEMENT, LLC with ownership of 6,332,945, which is approximately -1.095% of the company’s market cap and around 5.40% of the total institutional ownership; VANGUARD GROUP INC, holding 4,680,454 shares of the stock with an approximate value of $3.4 million in SRGA stocks shares; and STATE STREET CORP, currently with $3.34 million in SRGA stock with ownership of nearly 6.4% of the company’s market capitalization.

Positions in Surgalign Holdings Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 40 institutional holders increased their position in Surgalign Holdings Inc. [NASDAQ:SRGA] by around 7,890,469 shares. Additionally, 50 investors decreased positions by around 21,109,432 shares, while 21 investors held positions by with 16,061,179 shares. The mentioned changes placed institutional holdings at 45,061,080 shares, according to the latest SEC report filing. SRGA stock had 21 new institutional investments in for a total of 2,684,200 shares, while 21 institutional investors sold positions of 9,576,287 shares during the same period.